Benzinga | Dec 16, 2021 07:02AM EST

Seres Announces Preliminary SER-287 Phase 2b ECO-RESET Study Microbiome Data Analysis; Co. Reports 'microbiome data demonstrate the successful engraftment of SER-287'

-- Microbiome data demonstrate the successful engraftment of SER-287 --

-- Microbiome assessments suggest potential for biomarker-based patient selection --

-- Company continues to evaluate SER-287 study data, and available preliminary SER-301 Phase 1b study clinical and microbiome data, to inform plans for continued development in ulcerative colitis --